Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged a Granocyte YouTube video promoted a POM to the public, lacked prescribing information and wasnβt recertified. Panel found it was…
PMCPA ruled Norgineβs Feraccru promotional email overstated economic claims from a small abstract and in-house modelling, omitted key limitations, and downplayed IBD…
A senior Pfizer UK employee posted and another βlikedβ a LinkedIn update linking to a BBC article about the Pfizer/BioNTech Covid-19 vaccine…
Complaint alleged Jardiance webcast/slides misled on CV benefits, encouraged off-label use, and hosted outdated prescribing info publicly. PMCPA ruled no breach of…
Complaint alleged GSK promoted unlicensed RSV vaccine and Covid-19 antibody treatment to the public via LinkedIn. Panel ruled no breach of Clauses…
PMCPA ruled Novo Nordisk breached Clause 5.1 (high standards) after a Saxenda patient webpage listed an 0845 number for adverse event reporting…
Complaint about a Symbicort Turbu+ βpackage dealβ and Turbu+ website. Panel found no inducement to prescribe, but ruled breach where HCP-accessible package…
UK employees βlikedβ a US LinkedIn post about a Phase 3 trial for Enhertu. The Panel said the βlikesβ proactively disseminated the…
Six UK-based Lilly staff βlikedβ a US corporate LinkedIn post about investigational tirzepatide trial results. PMCPA ruled this proactively disseminated unlicensed promotion…
Anonymous nurse alleged a Sanofi account executive pressured them to sign up to a diabetes therapy review service βas a favourβ. Panel…
Complaint alleged off-label promotion linking Pergoveris to IVF and that a study slide lacked key methodological limitations. PMCPA Panel ruled no breach…
Roche UK hosted disease education pages on roche.co.uk that the Panel said were in scope of the ABPI Code and required certification.…
UsForThem complained about a BBC Health article quoting Pfizerβs CEO on vaccinating 5β11s. Appeal Board found breaches for misleading, unsubstantiated, unbalanced public…
Gileadβs HIV.eu HCP site briefly remained accessible after βvisit patient siteβ failed. Panel found promotional HCP content likely visible to the public…
Anonymous HCP said Ocrevus website claim βgenerally well toleratedβ was misleading given serious/fatal AEs in SPC. Panel found the claim sufficiently qualified…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.